CG
CARM

Cutler Group’s Carisma Therapeutics CARM Stock Holding History

Cutler Group’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5
Closed – – 2406
2023
Q4 		$0 Hold
5
– – ﹤0.01% 3664
2023
Q3 		$0 Hold
5
– – ﹤0.01% 3836
2023
Q2 		$0 Hold
5
– – ﹤0.01% 3620
2023
Q1 		$0 Hold
5
– – ﹤0.01% 3872
2022
Q4 		$0 Sell
5
-161
-97% -$1.69K ﹤0.01% 4453
2022
Q3 		$1K Buy
166
+125
+305% +$1.7K ﹤0.01% 4452
2022
Q2 		$0 Buy
41
+36
+720% +$412 ﹤0.01% 5010
2022
Q1 		$0 Sell
5
-811
-99% -$11.3K ﹤0.01% 5358
2021
Q4 		$13K Sell
816
-1,603
-66% -$32.3K ﹤0.01% 3470
2021
Q3 		$38K Buy
2,419
+133
+6% +$6.38K ﹤0.01% 2742
2021
Q2 		$211K Buy
2,286
+1,023
+81% +$65.2K 0.01% 1302
2021
Q1 		$65K Buy
1,263
+640
+103% +$30.2K ﹤0.01% 2124
2020
Q4 		$16K Buy
+623
New +$15.8K ﹤0.01% 2825
2019
Q4 		– Sell
-55
Closed -$1K – 4018
2019
Q3 		$1K Hold
55
– – ﹤0.01% 3674
2019
Q2 		$1K Buy
+55
New +$1.65K ﹤0.01% 3788
2019
Q1 		– Sell
-123
Closed -$3K – 4076
2018
Q4 		$3K Buy
123
+90
+273% +$2.87K ﹤0.01% 3134
2018
Q3 		$1K Buy
33
+10
+43% +$390 ﹤0.01% 3711
2018
Q2 		$0 Buy
23
+20
+667% +$881 ﹤0.01% 4236
2018
Q1 		$0 Hold
3
– – ﹤0.01% 4495
2017
Q4 		$0 Hold
3
– – ﹤0.01% 4956
2017
Q3 		$0 Sell
3
-20
-87% -$559 ﹤0.01% 5894
2017
Q2 		$0 Sell
23
-33
-59% -$1.1K ﹤0.01% 6384
2017
Q1 		$2K Sell
56
-5
-8% -$208 ﹤0.01% 5381
2016
Q4 		$2K Sell
61
-539
-90% -$23.7K ﹤0.01% 5557
2016
Q3 		$33K Buy
600
+585
+3,900% +$43.6K ﹤0.01% 2888
2016
Q2 		$0 Buy
+15
New +$380 ﹤0.01% 6654

Other funds holding CARM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cutler Group's CARM Position: Q1 2024 in Review

Cutler Group sold out of Carisma Therapeutics (CARM) in Q1 2024, closing a stake of 5 shares.

Cutler Group first reported a position in CARM in Q2 2016 and held it in 26 quarters. The position peaked at $211K in Q2 2021. 51 funds tracked by Wall St. Rank hold CARM as of Q1 2024.

  • Cutler Group reported no remaining Carisma Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 5 Carisma Therapeutics shares in Q1 2024.
  • Cutler Group first reported a position in Carisma Therapeutics in Q2 2016 and held it in 26 quarters.
  • Cutler Group's Carisma Therapeutics position peaked at $211K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.